Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMS 433771

Known as: BMS-433771, BMS433771 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Human respiratory syncytial virus (HRSV) is a major respiratory pathogen in newborn infants and young children and can also be a… Expand
  • table 1
  • table 2
2007
2007
A series of benzimidazole-based inhibitors of respiratory syncytial virus (RSV) fusion were optimized for antiviral potency… Expand
2007
2007
The effect of structural variation of the benzimidazol-2-one ring of RSV fusion inhibitors related to BMS-433771 (1) was examined… Expand
2007
2007
Extensive SAR studies and optimization of ADME properties of benzimidazol-2-one derivatives led to the identification of BMS… Expand
Review
2005
Review
2005
  • G. Gao
  • Expert opinion on investigational drugs
  • 2005
  • Corpus ID: 45601794
Searching for small molecules to inhibit envelope virus fusion has long been a frontier field for both academic research and the… Expand
Highly Cited
2004
Highly Cited
2004
ABSTRACT BMS-433771 was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication in vitro. It exhibited… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Highly Cited
2004
Highly Cited
2004
ABSTRACT BMS-433771 is a potent inhibitor of respiratory syncytial virus (RSV) replication in vitro. Mechanism of action studies… Expand